Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiger, T. R.
Right arrow Articles by Peeper, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiger, T. R.
Right arrow Articles by Peeper, D. S.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Invasion and Metastasis
[Cancer Research 65, 7033-7036, August 15, 2005]
© 2005 American Association for Cancer Research


Review Articles

The Neurotrophic Receptor TrkB in Anoikis Resistance and Metastasis: A Perspective

Thomas R. Geiger and Daniel S. Peeper

Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Requests for reprints: Daniel S. Peeper, Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Phone: 31-20-512-2002; Fax: 31-20-512-2011; E-mail: d.peeper{at}nki.nl.

Resistance to anoikis ("detachment-induced apoptosis") has been suggested to be a prerequisite for cancer cells to metastasize. In a functional screen for suppressors of anoikis, we identified the neurotrophic receptor TrkB. Upon s.c. inoculation in mice, TrkB-expressing cells formed highly invasive and metastatic tumors. Here, we discuss our findings within the context of the proposed role of TrkB in human malignancies and address the question of its feasibility as a target for cancer therapy.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. R. Geiger and D. S. Peeper
Critical Role for TrkB Kinase Function in Anoikis Suppression, Tumorigenesis, and Metastasis
Cancer Res., July 1, 2007; 67(13): 6221 - 6229.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Lahti, T. Teitz, and D. G. Stupack
Does Integrin-Mediated Cell Death Confer Tissue Tropism in Metastasis?
Cancer Res., June 15, 2006; 66(12): 5981 - 5984.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Osada, Y. Tatematsu, Y. Yatabe, Y. Horio, and T. Takahashi
ASH1 Gene Is a Specific Therapeutic Target for Lung Cancers with Neuroendocrine Features
Cancer Res., December 1, 2005; 65(23): 10680 - 10685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.